BI
BVF Inc Portfolio holdings
AUM
$2.8B
This Quarter Return
-18.74%
1 Year Return
+17.96%
3 Year Return
+404.14%
5 Year Return
+563.41%
10 Year Return
+5,885.83%
AUM
$404M
AUM Growth
+$404M
(-31%)
Cap. Flow
+$21M
Cap. Flow
% of AUM
5.19%
Top 10 Holdings %
Top 10 Hldgs %
67.69%
Holding
33
New
3
Increased
15
Reduced
4
Closed
1
Top Buys
1 |
Esperion Therapeutics
ESPR
|
$10.3M |
2 |
Cytokinetics
CYTK
|
$10M |
3 |
CPXX
CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
|
$8.82M |
4 |
CNCE
Concert Pharmaceuticals, Inc.
CNCE
|
$7.15M |
5 |
BPMC
Blueprint Medicines
BPMC
|
$6.53M |
Top Sells
1 |
LOXO
Loxo Oncology, Inc
LOXO
|
$17.4M |
2 |
Ironwood Pharmaceuticals
IRWD
|
$12.9M |
3 |
FPRX
Five Prime Therapeutics, Inc.
FPRX
|
$12.5M |
4 |
CytomX Therapeutics
CTMX
|
$35K |
5 |
CALA
Calithera Biosciences, Inc
CALA
|
$28.4K |
Sector Composition
1 | Healthcare | 64.43% |